• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用米非司酮(RU 486)在黄体期早期进行生育调节治疗。

Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.

作者信息

Gemzell-Danielsson K, Swahn M L, Svalander P, Bygdeman M

机构信息

Department of Obstetrics and Gynaecology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Hum Reprod. 1993 Jun;8(6):870-3. doi: 10.1093/oxfordjournals.humrep.a138157.

DOI:10.1093/oxfordjournals.humrep.a138157
PMID:8345076
Abstract

Mifepristone (RU 486) is an antiprogestin which interacts with progesterone at the receptor level. Administration of mifepristone immediately after ovulation does not upset the menstrual cycle. However, the maturation and function of the endometrium is inhibited and uterine contractility is changed. To test if these effects are sufficient to prevent implantation, 21 women agreed to use one single treatment with 200 mg mifepristone on day luteinizing hormone (LH) + 2 monthly as their only contraceptive method. The women were treated for 1-12 months. The time of the LH peak was determined in the urine by the women themselves using a rapid LH test (Ovu-quick, Organon). The overall number of cycles studied was 169. In 12 cycles the women were unable to detect the LH peak. In these cycles no treatment was given and the women advised to use barrier methods during the time to menstruation. The remaining 157 cycles with a detectable LH peak were all ovulatory based on plasma progesterone measurement. One pregnancy occurred. On the basis of the time of the LH peak, it was retrospectively calculated that in 124 cycles at least one act of intercourse occurred during the period 3 days before to 1 day after ovulation. The probability of pregnancy in this period of the menstrual cycle is thus 0.008. The women did not complain of any treatment-related side-effects apart from slight bleeding for 2-3 days starting a few days after the day of treatment in 35% of the cycles.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

米非司酮(RU 486)是一种抗孕激素,它在受体水平与孕酮相互作用。排卵后立即服用米非司酮不会扰乱月经周期。然而,子宫内膜的成熟和功能会受到抑制,子宫收缩性也会改变。为了测试这些作用是否足以防止着床,21名女性同意每月在黄体生成素(LH)+2日单次服用200毫克米非司酮作为唯一的避孕方法。这些女性接受了1至12个月的治疗。女性自己使用快速LH检测法(奥鲁快,欧加农公司)在尿液中测定LH峰值时间。总共研究了169个周期。在12个周期中,女性未能检测到LH峰值。在这些周期中未进行治疗,并建议女性在下次月经来潮前使用屏障避孕法。根据血浆孕酮测量,其余157个可检测到LH峰值的周期均为排卵周期。发生了1次妊娠。根据LH峰值时间进行回顾性计算,在124个周期中,至少有一次性交发生在排卵前3天至排卵后1天期间。因此,月经周期这一时期的妊娠概率为0.008。除了35%的周期在治疗后几天开始出现2至3天的轻微出血外,女性未抱怨任何与治疗相关的副作用。(摘要截短至250字)

相似文献

1
Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.用米非司酮(RU 486)在黄体期早期进行生育调节治疗。
Hum Reprod. 1993 Jun;8(6):870-3. doi: 10.1093/oxfordjournals.humrep.a138157.
2
Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.RU 486对由外源性人绒毛膜促性腺激素延长的黄体期子宫内膜维持的可变作用。
Clin Endocrinol (Oxf). 1989 Jul;31(1):15-23. doi: 10.1111/j.1365-2265.1989.tb00449.x.
3
Mode of action of RU 486.RU 486的作用机制。
Ann Med. 1993 Feb;25(1):61-4. doi: 10.3109/07853899309147859.
4
Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.米非司酮 - 醋酸甲羟孕酮序贯方案对卵巢功能、子宫内膜发育及激素参数的影响。
Contraception. 1996 Aug;54(2):79-86. doi: 10.1016/0010-7824(96)00138-2.
5
Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.奥那司酮(ZK 98.299):一种用于子宫内膜避孕的潜在抗孕激素。
Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):779-87. doi: 10.1016/0002-9378(95)90341-0.
6
Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.排卵后单次给予米非司酮对着床期子宫内膜成熟的影响。
Hum Reprod. 1994 Dec;9(12):2398-404. doi: 10.1093/oxfordjournals.humrep.a138458.
7
Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.两种抗孕激素(米非司酮和奥那司酮)对可能影响着床的子宫内膜因素的作用。
Fertil Steril. 1997 Jun;67(6):1046-53. doi: 10.1016/s0015-0282(97)81437-9.
8
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.在月经周期的增殖期和分泌期给予米非司酮对出血模式、激素参数及子宫内膜的影响。
Hum Reprod. 1988 Oct;3(7):915-21. doi: 10.1093/oxfordjournals.humrep.a136809.
9
Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.月经周期黄体期前半期使用抗孕激素在无激素变化情况下中断子宫内膜成熟:一种避孕潜力。
Fertil Steril. 1992 Aug;58(2):338-43. doi: 10.1016/s0015-0282(16)55200-5.
10
Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.每日服用抗孕激素RU 486诱导的子宫内膜成熟延迟:一种潜在的新避孕策略。
Am J Obstet Gynecol. 1992 Jul;167(1):60-5. doi: 10.1016/s0002-9378(11)91627-5.

引用本文的文献

1
Mifepristone as a non-emergency contraceptive among women of reproductive age: a protocol for systematic review and meta-analysis.米非司酮作为育龄期女性的非紧急避孕药:一项系统评价与荟萃分析方案
BMJ Open. 2024 Dec 4;14(12):e090402. doi: 10.1136/bmjopen-2024-090402.
2
Evolutionary divergence of embryo implantation in primates.灵长类动物胚胎植入的进化分歧。
Philos Trans R Soc Lond B Biol Sci. 2022 Dec 5;377(1865):20210256. doi: 10.1098/rstb.2021.0256. Epub 2022 Oct 17.
3
Towards an Improved Understanding of the Effects of Elevated Progesterone Levels on Human Endometrial Receptivity and Oocyte/Embryo Quality during Assisted Reproductive Technologies.
关于在辅助生殖技术中提高对孕酮水平升高对人类子宫内膜容受性和卵母细胞/胚胎质量影响的认识
Cells. 2022 Apr 21;11(9):1405. doi: 10.3390/cells11091405.
4
What Do We Know about Classical and Non-Classical Progesterone Receptors in the Human Female Reproductive Tract? A Review.我们对人类女性生殖道中的经典型和非经典型孕激素受体了解多少?综述。
Int J Mol Sci. 2021 Oct 19;22(20):11278. doi: 10.3390/ijms222011278.
5
Endometrial Receptivity Analysis (ERA): data versus opinions.子宫内膜容受性分析(ERA):数据与观点
Hum Reprod Open. 2021 Apr 14;2021(2):hoab011. doi: 10.1093/hropen/hoab011. eCollection 2021.
6
90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies.90 年的孕激素:妇科治疗中的选择性孕激素受体调节剂。
J Mol Endocrinol. 2020 Jul;65(1):T15-T33. doi: 10.1530/JME-19-0238.
7
Role of nuclear progesterone receptor isoforms in uterine pathophysiology.核孕激素受体亚型在子宫病理生理学中的作用。
Hum Reprod Update. 2015 Mar-Apr;21(2):155-73. doi: 10.1093/humupd/dmu056. Epub 2014 Nov 18.
8
Embracing post-fertilisation methods of family planning: a call to action.接纳受精后计划生育方法:行动呼吁。
J Fam Plann Reprod Health Care. 2013 Oct;39(4):244-6. doi: 10.1136/jfprhc-2013-100702.
9
Emergency contraception: potential role of ulipristal acetate.紧急避孕:醋酸乌利司他的潜在作用。
Int J Womens Health. 2010 Aug 9;2:53-61. doi: 10.2147/ijwh.s5865.
10
Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914.孕激素受体选择性调节剂 CDB-2914 单次早黄体期剂量对子宫内膜的影响。
Fertil Steril. 2010 Apr;93(6):2035-41. doi: 10.1016/j.fertnstert.2008.12.057. Epub 2009 Feb 6.